AR126620A1 - Método y sistemas para licuefacción de materiales carbonáceos - Google Patents

Método y sistemas para licuefacción de materiales carbonáceos

Info

Publication number
AR126620A1
AR126620A1 ARP220102038A ARP220102038A AR126620A1 AR 126620 A1 AR126620 A1 AR 126620A1 AR P220102038 A ARP220102038 A AR P220102038A AR P220102038 A ARP220102038 A AR P220102038A AR 126620 A1 AR126620 A1 AR 126620A1
Authority
AR
Argentina
Prior art keywords
liquefaction
systems
carbonaceous materials
electromagnetic radiation
methods
Prior art date
Application number
ARP220102038A
Other languages
English (en)
Inventor
Jeffrey Booth Ryan Harris Kaitlin Raleigh Cliff Schlaegle Steven Troiano Richard Conroy Wesley Badac
Original Assignee
Qwave Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qwave Solutions Inc filed Critical Qwave Solutions Inc
Publication of AR126620A1 publication Critical patent/AR126620A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Carbon And Carbon Compounds (AREA)

Abstract

Métodos para la licuefacción de materiales carbonáceos, que incluyen los métodos que utilizan la radiación electromagnética. Sistemas para la licuefacción de materiales carbonáceos. Los sistemas pueden incluir un conducto de circulación para mezclar los reactivos, y/o un aparato de calentamiento que se basa en la radiación electromagnética.
ARP220102038A 2021-07-21 2022-07-29 Método y sistemas para licuefacción de materiales carbonáceos AR126620A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163224406P 2021-07-21 2021-07-21

Publications (1)

Publication Number Publication Date
AR126620A1 true AR126620A1 (es) 2023-10-25

Family

ID=84979748

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220102038A AR126620A1 (es) 2021-07-21 2022-07-29 Método y sistemas para licuefacción de materiales carbonáceos

Country Status (3)

Country Link
CN (1) CN117693517A (es)
AR (1) AR126620A1 (es)
WO (1) WO2023001224A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329645B2 (en) * 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
EP2872120B1 (en) * 2012-07-16 2017-05-03 Nanoderm Sciences, Inc. Therapeutic nanoparticles with a polymyxin b as targeting agent
KR102585108B1 (ko) * 2014-12-16 2023-10-05 상하이 미큐알엑스 파마슈티컬 컴퍼니 리미티드 세균 감염의 치료를 위한 항미생물성 폴리믹신
US10449230B2 (en) * 2016-10-06 2019-10-22 The Regents Of The University Of California Polymyxin derived cell penetrating scaffolds
KR20190072579A (ko) * 2016-10-21 2019-06-25 알지파마 에이에스 폴리믹신-알기네이트 올리고머 콘주게이트
US20230141981A1 (en) * 2020-01-21 2023-05-11 Shanghai Micurx Pharmaceuticals Co., Ltd Novel compounds and composition for targeted therapy of kidney-associated cancers

Also Published As

Publication number Publication date
WO2023001224A1 (en) 2023-01-26
CN117693517A (zh) 2024-03-12

Similar Documents

Publication Publication Date Title
ECSP19072235A (es) Anticuerpos anti-ILT4 y fragmentos de unión a antígeno
CL2018002683A1 (es) Antígeno prostático específico de membrana dirigido a agentes de alta afinidad para la endo radio terapia del cáncer de próstata
CL2019001646A1 (es) Anticuerpos anti-ox40 y sus usos.
BR112017019334A2 (pt) métodos e sistemas para fornecer e receber informações para gerenciamento de riscos no campo
BR112016024554A8 (pt) conjunto de cabeça de trépano para recuperação de testemunhos
CU24432B1 (es) Sistema, método y nodo de distribución de energía para la distribución jerárquica de energía
CL2022002514A1 (es) Descubrimiento eficiente de servidores de computación de borde
MX2019013087A (es) Marco de montaje de sarta de perforación.
ES2184652B1 (es) Procedimiento para identificacion y verificacion.
CL2020001256A1 (es) Sistema de minería.
ZA202102344B (en) Method and system of identifying and quantifying a protein
AR126620A1 (es) Método y sistemas para licuefacción de materiales carbonáceos
BR112022015422A2 (pt) Capacidade de múltiplas técnicas de posicionamento de downlink
CL2021000754A1 (es) Aparato y método para medir objetivos
CO2024002104A2 (es) Métodos y sistemas para la licuefacción de materiales carbonosos
ECSP21043288A (es) Anticuerpos antiperiostina y usos de estos
CY1123624T1 (el) Συσκευη και μεθοδος εφαρμογης καλωδιων με μια ή περισσοτερες οπτικες ινες σε ενα σωληνα για χερσαιους ή υποθαλασσιους αγωγους
BR112019007365A2 (pt) métodos e composições para imunoterapia com tusc2
BR112022006882A2 (pt) Multiplexação de relatórios de informações de estado de canal em múltiplos cenários de pontos de transmissão recebimento (trp)
Hassan et al. A new class of BFGS updating formula based on the new quasi-newton equation
BR112018073014A2 (pt) métodos e materiais para estadiamento e tratamento de câncer de pele
BR112021006194A2 (pt) método, equipamento de usuário, programa de computador, e, portadora.
Citraresmana Konsep makna kita dan kami dalam debat capres bulan Januari 2019: Kajian semantik kognitif melalui studi korpus (the conceptual meanings of kita and kami in Indonesian. Metalingua, 17 (2), 103–112
Hanany MUSYKILÂT AT-TA’RÎB FÎ TATHAWURI AL-LUGHAH AL-ARABIYYAH
Teytelman Lenny's workshop slides